Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • RIGEL PHARMACEUTICALS INC Balance Sheet

  • View:
    Annual Data | Quarterly Data
    Period Ending FY2008 FY2007 FY2006 FY2005 FY2004
    Assets
    Cash and Short Term Investments 134.48 M 108.30 M 104.47 M 138.20 M 71.43 M
    Net Receivables 0.00 442,000.00 1.39 M 1.83 M 699,000.00
    Total Inventories 0.00 0.00 0.00 0.00 0.00
    Progress Payments & Others 0.00 0.00 0.00 0.00 0.00
    Prepaid Expenses
    Other Current Assets 3.61 M 2.39 M 2.15 M 2.57 M 2.11 M
    Current Assets Total 138.09 M 111.13 M 108.01 M 142.60 M 74.24 M
    Long Term Receivables 0.00 0.00 0.00 0.00 0.00
    Investment in Unconsolidated Subsidiaries 0.00 0.00 0.00 0.00 0.00
    Other Investments 0.00 0.00 0.00 0.00 0.00
    Property, Plant & Equipment Net 3.57 M 2.56 M 2.98 M 3.46 M 2.81 M
    Property, Plant & Equipment Gross 19.02 M 17.21 M 16.28 M 15.62 M 14.09 M
    Accumulated Depreciation 15.46 M 14.65 M 13.31 M 12.16 M 11.28 M
    Other Assets 2.20 M 2.10 M 2.25 M 1.62 M 1.77 M
    Deferred Charges
    Tangible Other Assets 2.20 M 2.10 M 2.25 M 1.62 M 1.77 M
    Intangible Other Assets
    Total Assets 143.86 M 115.79 M 113.24 M 147.67 M 78.82 M
    Liabilities
    Short Term Debt & Current Portion of Long Term Debt 1.34 M 990,000.00 1.27 M 1.07 M 1.32 M
    Accrued Payroll 1.62 M 8.13 M 3.06 M 2.19 M 1.64 M
    Income Taxes Payable 0.00 0.00 0.00 0.00 0.00
    Dividends Payable 0.00 0.00 0.00 0.00 0.00
    Other Current Liabilities 15.20 M 2.67 M 4.95 M 17.89 M 6.51 M
    Current Liabilities Total 24.15 M 16.11 M 11.24 M 23.65 M 11.42 M
    Long Term Debt 2.05 M 784,000.00 1.08 M 1.13 M 781,000.00
    Provision for Risks & Charges
    Deferred Taxes 0.00 0.00 0.00 0.00 0.00
    Deferred Income 13.31 M 16.49 M 13.33 M 13.89 M 13.86 M
    Deferred Tax Liability in Untaxed Reserves
    Other Liabilities 178,000.00 225,000.00 363,000.00 409,000.00 457,000.00
    Total Liabilities 39.69 M 33.61 M 26.01 M 39.08 M 26.52 M
    Shareholders Equity
    Non-Equity Reserves 0.00 0.00 0.00 0.00 0.00
    Minority Interest 0.00 0.00 0.00 0.00 0.00
    Preferred Stock 0.00 0.00 0.00 0.00 0.00
    Common Equity 104.16 M 82.18 M 87.23 M 108.59 M 52.30 M
    Common Stock 37,000.00 31,000.00 25,000.00 25,000.00 20,000.00
    Capital Surplus 605.51 M 451.38 M 382.35 M 366.20 M 264.82 M
    Revaluation Reserves 0.00 0.00 0.00 0.00 0.00
    Other Appropriated Reserves 0.00 0.00 0.00 -26,000.00 -56,000.00
    Unappropriated (Free) Reserves 0.00 0.00
    Retained Earnings -501.78 M -369.43 M -295.16 M -257.52 M -212.27 M
    Equity in Untaxed Reserves
    ESOP Guarantees 0.00 0.00 0.00 0.00 0.00
    Unrealized Foreign Exchange Gain (Loss) 0.00 0.00 0.00 0.00 0.00
    Unrealized Gain (Loss) on Marketable Securities 396,000.00 198,000.00 13,000.00 -92,000.00 -220,000.00
    Treasury Stock 0.00 0.00 0.00 0.00 0.00
    Total Liabilities & Shareholders Equity 143.86 M 115.79 M 113.24 M 147.67 M 78.82 M
    Common Shares Outstanding 36.65 M 31.38 M 25.18 M 24.81 M 19.66 M